Back to Search
Start Over
Daratumumab, Lenalidomide, and Dexamethasone for High-Risk Smoldering Multiple Myeloma
- Source :
- The Hematologist. 20
- Publication Year :
- 2023
- Publisher :
- American Society of Hematology, 2023.
- Subjects :
- General Medicine
Subjects
Details
- ISSN :
- 15518779
- Volume :
- 20
- Database :
- OpenAIRE
- Journal :
- The Hematologist
- Accession number :
- edsair.doi...........172ad3effacf719cd1e66e3513b5e9f8